How your customers see you
April 6, 2004When looking at the performance of new products there are many reasons for their possible success. Perhaps GPs hooked into …
Amgen pipeline boosted by $1.3bn Tularik acquisition
April 5, 2004US biotech Amgen is to buy gene regulation specialist Tularik in a move that will add five drug candidates to …
US accused of blocking generics AIDS drug plan
April 5, 2004Aid agencies are claiming that plans to provide antiretroviral treatment for millions of people with HIV are being undermined by …
Size isn’t everything
March 30, 2004Pharmaceutical company sales teams have grown significantly in size over the last few years the – figures vary, but by …
New antidepressant warnings in US and Britain
March 25, 2004New warnings about the prescribing of the Selective Serotonin Reuptake Inhibitor (SSRI) class of antidepressants have been issued in the …
Bayer feels cost of restructuring
March 25, 2004German pharmaceutical company Bayer has posted the biggest losses in its history after paying a hefty price for restructuring the …
Solvay and Altana to swap detailing time
March 25, 2004Altana Pharma and Solvay Healthcare are to launch a novel 'time-swap' co-promotional agreement to make the most of their salesforces' …
France pours cold water on Novartis talks
March 25, 2004Merger talks between Swiss pharma company Novartis and Franco-German Aventis could be in jeopardy after the French government indicated its …
New code for journals in wake of MMR conflict of interest
March 19, 2004MMR, journals
A new code of conduct has been drawn up for medical journals to help uncover conflicts of interest which could …
UK and US face up to public health crises
March 19, 2004The UK government has launched a consultation that it hopes will stimulate debate on how best to tackle the growing …
Latest content
FibroFind appoints Lee Borthwick as CEO
